» Articles » PMID: 37827145

The Causal Effect of Obesity on the Risk of 15 Autoimmune Diseases: A Mendelian Randomization Study

Overview
Journal Obes Facts
Publisher Karger
Specialty Endocrinology
Date 2023 Oct 12
PMID 37827145
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Observational studies have shown that obesity is a risk factor for various autoimmune diseases. However, the causal relationship between obesity and autoimmune diseases is unclear. Mendelian randomization (MR) was used to investigate the causal effects of obesity on 15 autoimmune diseases.

Methods: MR analysis employed instrumental variables, specifically single-nucleotide polymorphisms associated with obesity measures such as body mass index (BMI), waist circumference, hip circumference, and waist-to-hip ratio. The study utilized UK Biobank and FinnGen data to estimate the causal relationship between obesity and autoimmune diseases.

Results: Genetically predicted BMI was associated with risk for five autoimmune diseases. The odds ratio per 1-SD increase in genetically predicted BMI, the OR was 1.28 (95% CI, 1.18-1.09; p < 0.001) for asthma, 1.37 (95% CI, 1.24-1.51; p < 0.001) for hypothyroidism, 1.52 (95% CI, 1.27-1.83; p < 0.001) for psoriasis, 1.22 (95% CI, 1.06-1.40; p = 0.005) for rheumatoid arthritis, and 1.55 (95% CI, 1.32-1.83; p < 0.001) for type 1 diabetes. However, after adjusting for genetic susceptibility to drinking and smoking, the correlation between BMI and rheumatoid arthritis was not statistically significant. Genetically predicted waist circumference, hip circumference, and waist and hip circumference were associated with 6, 6, and 1 autoimmune disease, respectively.

Conclusion: This study suggests that obesity may be associated with an increased risk of several autoimmune diseases, such as asthma, hypothyroidism, psoriasis, rheumatoid arthritis, and type 1 diabetes.

Citing Articles

Large-scale analysis highlights obesity as a risk factor for chronic, non-communicable inflammatory diseases.

Mousavi S, Bieber K, Zirpel H, Vorobyev A, Olbrich H, Papara C Front Endocrinol (Lausanne). 2025; 16:1516433.

PMID: 39963282 PMC: 11830592. DOI: 10.3389/fendo.2025.1516433.


Associations between type 1 diabetes and autoimmune skin diseases: Mendelian randomization analysis.

Liu J, Xu Y, Liu Y, Zhu Y, Li X Heliyon. 2024; 10(12):e32781.

PMID: 38975116 PMC: 11226843. DOI: 10.1016/j.heliyon.2024.e32781.


Biomarkers in Systemic Lupus Erythematosus along with Metabolic Syndrome.

Corona-Meraz F, Vazquez-Del Mercado M, Sandoval-Garcia F, Robles-De Anda J, Tovar-Cuevas A, Rosales-Gomez R J Clin Med. 2024; 13(7).

PMID: 38610754 PMC: 11012563. DOI: 10.3390/jcm13071988.

References
1.
Matarese G . The link between obesity and autoimmunity. Science. 2023; 379(6639):1298-1300. DOI: 10.1126/science.ade0113. View

2.
Budu-Aggrey A, Brumpton B, Tyrrell J, Watkins S, Modalsli E, Celis-Morales C . Evidence of a causal relationship between body mass index and psoriasis: A mendelian randomization study. PLoS Med. 2019; 16(1):e1002739. PMC: 6354959. DOI: 10.1371/journal.pmed.1002739. View

3.
Larsson S, Burgess S . Causal role of high body mass index in multiple chronic diseases: a systematic review and meta-analysis of Mendelian randomization studies. BMC Med. 2021; 19(1):320. PMC: 8672504. DOI: 10.1186/s12916-021-02188-x. View

4.
Sterry W, Strober B, Menter A . Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol. 2007; 157(4):649-55. DOI: 10.1111/j.1365-2133.2007.08068.x. View

5.
Do M, Wang X, Zhang X, Chou C, Nixon B, Capistrano K . Nutrient mTORC1 signaling underpins regulatory T cell control of immune tolerance. J Exp Med. 2019; 217(1). PMC: 7037250. DOI: 10.1084/jem.20190848. View